期刊文献+

前列腺特异性抗体电化学免疫传感器研制

Development of PSA immunology electrochemical biosensor
在线阅读 下载PDF
导出
摘要 制得自组装巯基丁二胺铜(Ⅱ)/纳米金胶/前列腺特异性(PSA)抗体免疫传感器。在pH=5.2的磷酸盐底液中,采用示差脉冲法对PSA进行定量测定。结果显示:该传感器的氧化峰电流减少值与PSA浓度在0.005—0.48mg/L范围内成线性关系,检测下限为2μg/L。在40μg/LPSA浓度下测量RSD=2.9%(n=8),该免疫传感器稳定性和抗干扰性较好。检测血清中PSA结果满意。 A mercaptobutamine combined Cu (Ⅱ) absorbing Au colloid/PSA antibody biosensor for the determination of PSA in serum is reported. The modified electrode is simply self-assembly prepared. In PBS buffer solution of pH 5.2, differential-pulse voltammetry(DPV) is used for measurement. The peak currents of catholic DPV peaks decrease with the addition of PSA into the buffer solution while the peak potentials remain the same. The decreasing value of peak current is linear with PSA concentration in the range of 0. 005 -0.48 mg/L. The detection limit is 2 μg/L. And the relative standard deviation for 40 μg/L PSA is 2.9 % (n =8). The stability of this electrode is satisfactory without serious interference. The method is successfully employed to determine PSA antigen in serum samples.
出处 《传感器与微系统》 CSCD 北大核心 2007年第12期91-93,96,共4页 Transducer and Microsystem Technologies
基金 浙江省科技攻关计划资助项目(006C00)
关键词 自组装 巯基丁二胺铜(Ⅱ) 纳米金胶 前列腺特异性抗体 血清 self-assemble mercaptobutamine Cu (Ⅱ) nano Au colloid PSA antigen serum
  • 相关文献

参考文献8

二级参考文献37

  • 1[1]Christensson A,Bjork T,Nisson O,et al.Serum prostate specific antigen complexed to α 1-antichymotrypsim as an indicator of prostate cancer[J].J Urol,1993,150:100-105.
  • 2Shin Egawa, Shigehiro Soh, Makoto Ohori, et al, The ratio of free to total serum prostate specific antigen and its use in differential diagnosis or prostate carcinoma in Japan. Cancer, 1997,79:90-98.
  • 3Wang MC, Valeuzula La, Murphy Gp, et al. Purification of a human prostate specific antigen. Invest Urol, 1979,17:159-163.
  • 4Arai Y, Yoshiki T,Okada KL, et al. Multiple marker evaluation in prostatic cancer using prostatic specific antigen , gammaseminoprotein and prostatic acid phosphatase. Urol Int, 1989,44 :135.
  • 5Dupont A, Cusan L, Gomez JL, et al. Prostate specific antigen and prostatic acid phosphtase for monitoring therapy of carcinoma of the prostate. J Urol, 1991,146T1064.
  • 6Arai Y, Yoshiki T,Okada KL, et al. Multiple marker evaluation in prostatic cancer using prostatic specific antigen , gamma-seminoprotein and prostatic acid phosphatase.Urol Int, 1989,44:135.
  • 7Dupont A, Cusan L, Gomez JL, et al. Prostate specific antigen and prostatic acid phosphtase for monitoring therapy of carcinoma of the prostate.J Urol, 1991,146:1064.
  • 8Shin Egawa, Shigehiro Soh, Makoto Ohori, et al, The ratio of free to total serum prostate specific antigen and its use in differential diagnosis or prostate carcinoma in Japan. Cancer, 1997,79:90-98.
  • 9Wang MC, Valeuzula La, Murphy Gp, et al. Purification of a human prostate specific antigen.Invest Urol,1979,17:159-163.
  • 10Nag S.Brachytherapy for prostate cancer:summary of american brachytherapy society recommendations.Semin Urol Oncol,2000,18:133-136.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部